Nucleic in Medical Technology
Navigation Links
Nucleic in Medical Technology
... (MALDI-TOF) mass spectrometry-based nucleic acid analysis platform that quantitatively ... MassARRAY system facilitates a number of nucleic acid analysis applications including single ... system allows a direct mass measurement of nucleic acids, providing unparalleled precision and ...
... extraction, isolation, and fractionation of nucleic acids (DNA and RNA), proteins, and lipids ... studies. This method also yields high recovery of nucleic acids and proteins, shows ... extraction, isolation, and fractionation of nucleic acids, proteins, and lipids from a wide variety ...
... of its US patent "Methods for detection of nucleic acid sequences in urine," RE39,920 that covers use of its proprietary transrenal nucleic acid technology in the area of infectious disease diagnostics and monitoring. Transrenal nucleic acids (Tr-DNA and Tr-RNA) are fragments of DNA ...
... amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect, and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed ...
... amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed ...
... /PRNewswire/ --IntelligentMDx a developer and manufacturer of proprietary nucleic acid assays, today announced that verification studies of the ... test functionality. IntelligentMDx's current pipeline includes proprietary nucleic acid (DNA or RNA) tests for Real Time PCR. These tests cover a range of ...
... amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed ...
... amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed ...
... agent. The REG1 anticoagulant component, RB006, is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits factor ... to blood coagulation. The reversal agent, RB007, is a complementary nucleic acid that binds to and neutralizes RB006. The amount of RB007 administered ...
... amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed ...
... consumable products and automated solutions for sample collection, nucleic acid and protein handling, separation, and purification and open and ... applied testing markets, clinical research markets and proteomics markets, nucleic acid-based molecular diagnostics market, and genetic vaccination and gene ...
... amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed ...
... with Abbott for the development and commercialization of molecular, or nucleic acid-based, diagnostic products, and is also developing new diagnostic ... consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific ...
... system, consisting of an aptamer-based anticoagulant and its matched antidote. The REG1 anticoagulant component (RB006) is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits Factor IXa, a protein that is critical to blood coagulation. The antidote ...
... Laboratory: The Columbia University Medical Center Molecular Pathology Laboratory is a high complexity molecular pathology laboratory that provides nucleic acid-based testing in the fields of molecular oncology and molecular genetics, with New York state permits in the categories of genetic testing, ...
... accurate APTIMA HPV assay that improves the detection and treatment of cervical cancer." The investigational APTIMA HPV assay is an amplified nucleic acid test that detects 14 high-risk HPV types that are associated with cervical cancer. More specifically, the assay detects two messenger RNAs ...
... about 50 percent of the $2 billion molecular diagnostics market in the United States. The assay development research relies on NUI Galway nucleic acid detection technology for both bacterial and fungal targets along with SPRI(R) (Solid Phase Reversible Immobilization) and other technologies ...
... molecule chemotherapeutic agent that inhibits dihydrofolate reductase, or DHFR, a folic acid (folate)-dependent enzyme involved in the building of nucleic acid, or DNA, and other processes. PDX was rationally designed for efficient transport into tumor cells via the reduced folate carrier, or RFC-1, and ...
... system, consisting of an aptamer-based anticoagulant and its matched antidote. The REG1 anticoagulant component (RB006) is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits Factor IXa, a protein that is critical to blood coagulation. The antidote ...
... system, consisting of an aptamer-based anticoagulant and its matched antidote. The REG1 anticoagulant component (RB006) is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits Factor IXa, a protein that is critical to blood coagulation. The antidote ...
... QIAGEN has developed a comprehensive portfolio of more than 500 proprietary, consumable products and automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification. QIAGEN also supplies diagnostic kits, tests, and assays for human and veterinary molecular ...
... molecule chemotherapeutic agent that inhibits dihydrofolate reductase, or DHFR, a folic acid (folate)-dependent enzyme involved in the building of nucleic acid, or DNA, and other processes. PDX was rationally designed for efficient transport into tumor cells via the reduced folate carrier, or RFC-1, and ...
Another LNA-based RNA Inhibitor Enters Clinical Trials
... "Androgen receptor (AR) down regulation by locked nucleic acid antisense oligonucleotides specifically ... antagonist" "EZN-3042, a novel locked nucleic acid oligonucleotide against survivin, inhibits ... PEGylation technology platform and the Locked nucleic Acid (LNA) technology. Enzon's PEGylation ...... extraction, isolation, and fractionation of nucleic acids (DNA and RNA), proteins, and lipids ... studies. This method also yields high recovery of nucleic acids and proteins, shows ... extraction, isolation, and fractionation of nucleic acids, proteins, and lipids from a wide variety ...
... of its US patent "Methods for detection of nucleic acid sequences in urine," RE39,920 that covers use of its proprietary transrenal nucleic acid technology in the area of infectious disease diagnostics and monitoring. Transrenal nucleic acids (Tr-DNA and Tr-RNA) are fragments of DNA ...
... amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect, and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed ...
... amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed ...
DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology
... used with a diverse group of drug candidates, from proteins, peptides and nucleic acids to small molecule drugs, thus expanding the possible application ... based therapies in oncology, immunology and on the delivery of nucleic acids. " Through this deal we bring in the first biodegradable ...... /PRNewswire/ --IntelligentMDx a developer and manufacturer of proprietary nucleic acid assays, today announced that verification studies of the ... test functionality. IntelligentMDx's current pipeline includes proprietary nucleic acid (DNA or RNA) tests for Real Time PCR. These tests cover a range of ...
... amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed ...
... amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed ...
... agent. The REG1 anticoagulant component, RB006, is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits factor ... to blood coagulation. The reversal agent, RB007, is a complementary nucleic acid that binds to and neutralizes RB006. The amount of RB007 administered ...
... amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed ...
... consumable products and automated solutions for sample collection, nucleic acid and protein handling, separation, and purification and open and ... applied testing markets, clinical research markets and proteomics markets, nucleic acid-based molecular diagnostics market, and genetic vaccination and gene ...
... amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed ...
... with Abbott for the development and commercialization of molecular, or nucleic acid-based, diagnostic products, and is also developing new diagnostic ... consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific ...
New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects
... on angiostatic miRNAs. miRNA is utilized as a therapeutic modality and advanced nanoparticle delivery systems accomplish intracellular delivery of nucleic acid agents. These will be combined with the identification of surface receptor targets on tumor blood vessels to allow for therapeutic intervention. ...TriLink Launches CleanAmp(TM) dNTPs for Hot Start PCR
... SAN DIEGO, May 6 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink), a leading provider of custom nucleic acid-based compounds, has launched a new Hot Start PCR reagent - CleanAmp(TM) dNTPs. CleanAmp(TM) dNTPs offer a less expensive solution to ...Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis
... About Gen-Probe Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT ...Gen-Probe and DiagnoCure Amend Collaboration Agreement Surrounding PCA3-Based Prostate Cancer Tests
... About Gen-Probe Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT ...Data Suggests New Antigen-Antibody Combo Test Useful for High Volume Public Health Screening
... from the Global HIV Surveillance Program at Abbott. "The current method for detection of acute infections is expensive and labor- intensive pooled nucleic acid testing (NAAT). The combination assay represents a reliable and cost-effective alternative with important benefits for HIV prevention ...Breakthrough in Prenatal Screening for Down Syndrome
... medical director Dr. Stephen A. Brown at the University of Vermont incorporates the use of methylation-sensitive amplification (MSA) of fetal nucleic acid markers. In the preliminary studies, more than ten clinical plasma specimens of various ethnicities provided by clinical partners were tested ...Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
... system, consisting of an aptamer-based anticoagulant and its matched reversal agent. The anticoagulant component, RB006, is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits factor IXa, a protein that is critical to blood coagulation. The reversal agent, ...Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172
... be reversed with protamine once the procedure has been completed. About Aptamers and NU172 Aptamers are chemically synthesized single-stranded nucleic acids that form well-defined three-dimensional shapes, allowing them to bind target molecules in a manner that is conceptually similar to ...... system, consisting of an aptamer-based anticoagulant and its matched antidote. The REG1 anticoagulant component (RB006) is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits Factor IXa, a protein that is critical to blood coagulation. The antidote ...
Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
... 10 minutes. No serious adverse events occurred in the trial. About Aptamers and NU172 Aptamers are chemically synthesized single-stranded nucleic acids that form well-defined three-dimensional shapes, allowing them to bind target molecules in a manner that is conceptually similar to ...TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project
... SAN DIEGO, May 6 /PRNewswire/ -- TriLink BioTechnologies (TriLink), a leading provider of custom nucleic acid-based compounds, has been awarded a Phase II Small Business Innovation Research (SBIR) grant of approximately $750,000 to continue its ...Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172
... standard of care for anticoagulation in CABG surgeries and PCI. About Aptamers and NU172 Aptamers are chemically synthesized single-stranded nucleic acids that form well-defined three-dimensional shapes, allowing them to bind target molecules in a manner that is conceptually similar to ...... Laboratory: The Columbia University Medical Center Molecular Pathology Laboratory is a high complexity molecular pathology laboratory that provides nucleic acid-based testing in the fields of molecular oncology and molecular genetics, with New York state permits in the categories of genetic testing, ...
... accurate APTIMA HPV assay that improves the detection and treatment of cervical cancer." The investigational APTIMA HPV assay is an amplified nucleic acid test that detects 14 high-risk HPV types that are associated with cervical cancer. More specifically, the assay detects two messenger RNAs ...
Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
... onset and offset of action, and avoidance of heparin-induced thrombocytopenia. About Aptamers Aptamers are chemically synthesized single-stranded nucleic acids that form well-defined three-dimensional shapes, allowing them to bind target molecules in a manner that is conceptually similar to ...... about 50 percent of the $2 billion molecular diagnostics market in the United States. The assay development research relies on NUI Galway nucleic acid detection technology for both bacterial and fungal targets along with SPRI(R) (Solid Phase Reversible Immobilization) and other technologies ...
... molecule chemotherapeutic agent that inhibits dihydrofolate reductase, or DHFR, a folic acid (folate)-dependent enzyme involved in the building of nucleic acid, or DNA, and other processes. PDX was rationally designed for efficient transport into tumor cells via the reduced folate carrier, or RFC-1, and ...
... system, consisting of an aptamer-based anticoagulant and its matched antidote. The REG1 anticoagulant component (RB006) is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits Factor IXa, a protein that is critical to blood coagulation. The antidote ...
... system, consisting of an aptamer-based anticoagulant and its matched antidote. The REG1 anticoagulant component (RB006) is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits Factor IXa, a protein that is critical to blood coagulation. The antidote ...
Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
... system, consisting of an aptamer-based anticoagulant and its matched antidote. The REG1 anticoagulant component (RB006) is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits Factor IXa, a protein that is critical to blood coagulation. The antidote ...... QIAGEN has developed a comprehensive portfolio of more than 500 proprietary, consumable products and automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification. QIAGEN also supplies diagnostic kits, tests, and assays for human and veterinary molecular ...
... molecule chemotherapeutic agent that inhibits dihydrofolate reductase, or DHFR, a folic acid (folate)-dependent enzyme involved in the building of nucleic acid, or DNA, and other processes. PDX was rationally designed for efficient transport into tumor cells via the reduced folate carrier, or RFC-1, and ...
Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
... for identification of human tyrosyl- DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC305831) as an inhibitor of Tdp1," nucleic Acids Research, http://nar.oxfordjournals.org/, Copyright (C) 2007 Oxford University Press. About Immtech Pharmaceuticals, Inc. Immtech ...Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
... molecule chemotherapeutic agent that inhibits dihydrofolate reductase, or DHFR, a folic acid (folate)-dependent enzyme involved in the building of nucleic acid, or DNA, and other processes. PDX was rationally designed for efficient transport into tumor cells via the reduced folate carrier, or RFC-1, and ...Other ContentscollagencollagencollagencollagencollagencollagencollagencollagendescentdescentdescentdescentdescentcommoncommoncommoncommoncommoncommoncommoncommoncommoncommonexclusionexclusionexclusionexclusionexclusioncompetitivecompetitivecompetitivecompetitivecompetitivecompetitivebioinformaticsbioinformaticsbioinformaticsbioinformaticsbioinformaticsbioinformaticsOther TagsAllograftCagesteerableTPS
(Date:11/25/2009)...e course of a lifetime, the heart pumps some 250 m...der to do this, the muscle fibers of the heart hav...ed by Dr. Wolfgang Rottbauer, vice chair of the De...Hospital (Chairman: Prof. Dr. H. A. Katus), has di...bility of the smallest muscular unit, the sarcomer...
(Date:11/24/2009)...us Research Institute (LRI) today named 12 new gra...million, recognize innovative work across a broad ...their creativity, novelty, and potential to drive ... and cure the complex disease of systemic lupus. ,...lupus researchers across the nation and include in...
(Date:11/24/2009)...mic-level action of a remarkable class of ring-sha...rs with the Lawrence Berkeley National Laboratory ...ystallography beamline at the Advanced Light Sourc...n gene expression and replication, and are vital t... infectious agents, such as the human papillomavir...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4NIMBioS hosts tutorial on optimal control and optimization for biologists 10071 1New Parkinsons Drug Draws Mixed Reviews 58192 1New Parkinsons Drug Draws Mixed Reviews 58192 2New Parkinsons Drug Draws Mixed Reviews 58192 3Minorities Less Likely to Have Blood Pressure Under Control 58190 1Minorities Less Likely to Have Blood Pressure Under Control 58190 2Minorities Less Likely to Have Blood Pressure Under Control 58190 3(Date:11/27/2009)... Three new interactive anatomy education apps fr...expand health sciences learning opportunities for ...urham, NC (Vocus) November 27, 2009 -- Modality, ... a division of Wolters Kluwer Health, today announ...n apps on the App Store. Clemente’s Anatomy,...
(Date:11/26/2009)...ng drug tetrathiomolybdate (TM) has been shown in ... disease, a disease caused by an overload of coppe...own. Very little, however, is known about how the ... led by Northwestern University researchers now ha...al structure of TM bound to copper-loaded metalloc...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center, a ... is one of a growing number of physicians who are ...es to connect with individuals who are interested ...obesity. Dr. Kim is utilizing Facebook to share be...actice with the community. , ...
(Date:11/25/2009)...., Nov. 25 When most pe...tist. But a chiropractor can also give patients t...dibular Joint, which is where your jaw (mandible) ... ,, The most common symptoms associated with T...popping of the jaw. But many other symptoms can b...
(Date:11/25/2009)...v. 25 /PRNewswire/ - Sentinelle Medical Inc., a le...d visualization software launches a suite of new l... medical imaging software platform at this year,s ...l meeting in Chicago, Nov. 30 - Dec. 5, 2009 (Boot...que high quality images generated by Sentinelle,s ...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4[0] Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store[1] Research sheds light on workings of anti-cancer drug[1] Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients[1] TMJ and Chiropractic Care: An Overall Wellness Approach[1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology
AllograftCageIntervertebralNeuroendoscopeProximitysteerableGingivoplastyHSMMotordrillZMMEmaxRadiotranslucentRetractionTPS
Other Tagsoncology 2oncology 3clusters 2clusters 3clusters 4partnership 2partnership 3partnership 4details 2details 3details 4details 5details 6details 7details 8details 9dynamics 2dynamics 3dynamics 4dynamics 5
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |